JOHANNESBURG - South African pharmaceutical company, Aspen, has announced regulatory approval for its generic injectable semaglutide.
Drugs that contain semaglutide, like Ozempic, are used to control blood sugar in adults with type 2 diabetes.
They've also become popular as a way for people to lose weight.
READ | Hidden burden of diabetes in the workplace
Aspen has received approval for the product in Canada and regulators have now given it the green light in Brazil and South Africa.
The company says it expects to start selling the drug over the next few months.
More generics on the market should help to reduce costs.